Pathways to Recovery and Resilience in Breast Cancer Survivorship
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Psychosocial Oncology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 388
Special Issue Editor
Interests: affective and cognitive neuroscience; neurocognitive interventions empowering resilience; building resilience in women with a breast cancer diagnosis
Special Issue Information
Dear Colleagues,
While medical advances have led to higher survival rates in breast cancer, less attention has been focused on the psychological needs of women to rebuild their lives after breast cancer treatment. Psychological support is also scarce in metastatic breast cancer care, yet increasing amounts of research show that psychological well-being affects clinical outcomes. In breast cancer, anxiety and depression have been shown to increase the risk of mortality by up to 30%, and risk factors such as cognitive decline, social support, and age have not been factored into the care pathway.
There is an urgent need to understand the mechanisms behind vulnerability in women with a primary or secondary (metastatic) diagnosis, to enable the provision of the best care possible at the right time. This will not only be of patient benefit but will save considerable time, labor, and financial resources in medicine.
This Special Issue brings together early and senior researchers. It will highlight their progressive and stepchange research on how to best support building resilience in survivorship. Theoretical advances using social, cognitive, and affective neuroscience, as well as qualitative methods, can provide the grounds for promising applications in clinical science. Insights from methods such as artificial intelligence (AI) and machine learning are welcome, as they can be highly informative in the early identification of risk factors in emotional vulnerability, with implications for prevention. Similarly, AI can help build personalized tools for managing symptoms and empowering women. We welcome submissions from researchers all around the world that contribute to this timely Special Issue. We hope that it can make a difference by raising awareness and implementing new research in cancer care.
I look forward to receiving your contributions.
Prof. Dr. Nazanin Derakhshan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- intervention
- mixed methods
- digital health
- personalized care
- AI
- resilience
- anxiety
- depression
- neuroscience
